HEC 68498
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Sunshine Lake Pharma Co., Ltd.
Overview
HEC 68498 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
HEC 68498 clinical trials
Explore related
Medical disclaimer. This page summarizes research about HEC 68498 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.